Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ALNY
ALNY logo

ALNY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ALNY News

Alnylam to Present New Vutrisiran Data at Heart Failure 2026

6d agoNewsfilter

Alnylam Pharmaceuticals Q1 Results Exceed Expectations

May 03 2026Yahoo Finance

Alnylam Pharmaceuticals Q1 2026 Earnings Call Highlights

Apr 30 2026seekingalpha

Alnylam Pharmaceuticals Q1 Earnings Exceed Expectations

Apr 30 2026seekingalpha

Alnylam Pharmaceuticals Q1 Earnings Announcement Scheduled

Apr 29 2026seekingalpha

ETF Analysis: FDG Implies 18.96% Upside Potential

Apr 24 2026NASDAQ.COM

Transformation of Value in Biotechnology Sector

Apr 20 2026Globenewswire

Biotechnology Sector Undergoes Value Transformation

Apr 20 2026Newsfilter

CGGR Stock Price Analysis and ETF Dynamics

Apr 17 2026NASDAQ.COM

Vutrisiran Enhances Quality of Life for ATTR-CM Patients

Mar 30 2026Newsfilter

Alnylam Advances Early Diagnosis and Care for ATTR-CM

Mar 24 2026Newsfilter

Analysis of IBB ETF Trading Dynamics

Mar 20 2026NASDAQ.COM

Analysis of IBB ETF Trading Dynamics

Mar 11 2026NASDAQ.COM

BridgeBio's Promising Biotech Pipeline Highlighted by William Blair

Mar 10 2026Benzinga

Tenaya Partners with Alnylam for Heart Drug Development

Mar 06 2026stocktwits

Health Care Stocks Decline, NYSE Health Care Index Drops 2.3%

Mar 05 2026Yahoo Finance